The expression levels of POLR2J and its co-expressed genes can predict outcomes in GBM patients, suggesting that oxidative stress, regulated by POLR2J, plays a significant role in the aggressiveness of the tumor and the overall prognosis for patients [126]. This evidence concerns the gene POLR2J and neoplasm.